Difference between revisions of "Day CW, et al, Virology (2009), cited as Ref 31 in DOI:10.1007/s11886-020-01292-3 (Q10540)"
Jump to navigation
Jump to search
(Created claim: Fifth Author string (P153): Kumaki Y, #quickstatements; #temporary_batch_1592503455634) |
(Created claim: Sixth Author string (P154): Morrey JD, #quickstatements; #temporary_batch_1592503575618) |
||
| Property / Sixth Author string | |||
| + | Morrey JD | ||
| Property / Sixth Author string: Morrey JD / rank | |||
| + | Normal rank | ||
Revision as of 18:06, 18 June 2020
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Day CW, et al, Virology (2009), cited as Ref 31 in DOI:10.1007/s11886-020-01292-3
|
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
|
Statements
Q10356 (Deleted Item)
0 references
A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivo (English)
0 references
Day CW
0 references
Baric R
0 references
Cai SX
0 references
Frieman M
0 references
Kumaki Y
0 references
Morrey JD
0 references
